Growth Metrics

Ultragenyx Pharmaceutical (RARE) Shareholder's Equity (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 595,226.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 19.36 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 31.42 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.08 Bn
10 Ultragenyx Pharmaceutical 2.29 Bn 1.89 Bn 106.00 Mn -236.00 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -236.00 Mn
Dec 31, 2025 -80.00 Mn
Sep 30, 2025 9.16 Mn
Jun 30, 2025 151.29 Mn
Mar 31, 2025 144.00 Mn
Dec 31, 2024 255.00 Mn
Sep 30, 2024 346.83 Mn
Jun 30, 2024 432.42 Mn
Mar 31, 2024 140.26 Mn
Dec 31, 2023 275.00 Mn
Sep 30, 2023 31.71 Mn
Jun 30, 2023 129.03 Mn
Mar 31, 2023 220.48 Mn
Dec 31, 2022 352.00 Mn
Sep 30, 2022 468.83 Mn
Jun 30, 2022 678.07 Mn
Mar 31, 2022 796.42 Mn
Dec 31, 2021 922.56 Mn
Sep 30, 2021 933.67 Mn
Jun 30, 2021 972.17 Mn
Mar 31, 2021 1.05 Bn
Dec 31, 2020 1.15 Bn
Sep 30, 2020 666.19 Mn
Jun 30, 2020 695.59 Mn
Mar 31, 2020 609.15 Mn
Dec 31, 2019 653.76 Mn
Sep 30, 2019 727.27 Mn
Jun 30, 2019 819.79 Mn
Mar 31, 2019 886.73 Mn
Dec 31, 2018 608.91 Mn
Sep 30, 2018 662.60 Mn
Jun 30, 2018 703.97 Mn
Mar 31, 2018 723.66 Mn
Dec 31, 2017 383.45 Mn
Sep 30, 2017 365.56 Mn
Jun 30, 2017 429.45 Mn
Mar 31, 2017 488.48 Mn
Dec 31, 2016 473.97 Mn
Sep 30, 2016 455.89 Mn
Jun 30, 2016 443.90 Mn
Mar 31, 2016 92,000.00
Dec 31, 2015 531.09 Mn
Sep 30, 2015 576.76 Mn
Jun 30, 2015 319.28 Mn
Mar 31, 2015 341.12 Mn
Dec 31, 2014 184.95 Mn
Sep 30, 2014 199.33 Mn
Jun 30, 2014 153.08 Mn
Mar 31, 2014 165.71 Mn
Dec 31, 2013 -74.82 Mn